Israel Corporation Ltd (IRLCF) Stock Price & Analysis
Israel Corporation Ltd (IRLCF) — price $24.85 (0.00%), as of the Nov 19, 2026 trading session; market cap $1.91B.
Educational signal · not a buy or sell recommendation · How to read this
Israel Corporation Ltd · IRLCF · Basic Materials · Chemicals Specialty
Israel Corporation Ltd conducts its global operations through subsidiary and affiliated entities, concentrating on the specialized mineral and refining industries.
Price as of Nov 19, 2026
Key Statistics
Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.
Thousands of the 20,000+ US stocks here carry a MoonshotScore.
Scored companies in the same industry:
- AXTA · Axalta Coating Systems Ltd. · 69 /100
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $24.85 | |
| Change on the day | 0.00% | |
| 52-week range | $24.85–$280.00 | |
| Market capitalisation | $1.91B | — |
| Price / earnings (trailing) | 14.16 | |
| Shares traded on the day | 1 | |
| Beta (volatility vs the S&P 500) | 0.18 | |
| Dividends per share (last 12 months) | $0.17 | |
| Dividend yield (last 12 months) | 0.06% |
Price & events
Triangles mark reported quarters on the line: pointing up is above the recorded estimate, down is below, a diamond means no estimate on file. Numbers key to the dated list. Point at or tab to any week for its close.
Events behind the price
- · Earnings results
- · Earnings results
- · Earnings results
Results dates follow the earnings feed; call dates follow the transcript provider. Nearby dates do not establish that an event caused a price move.
Other perspectives
Council score for Israel Corporation (IRLCF): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
4 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Sep 8, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Apr 29, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Apr 29, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Israel Corporation (IRLCF), and what does it report?
Short answer
Israel Corporation Ltd conducts its global operations through subsidiary and affiliated entities, concentrating on the specialized mineral and refining industries. Israel Corporation Ltd (IRLCF) is classified as Basic Materials / Chemicals Specialty. Headquarters: Millennium Tower, Tel Aviv, TA, 61204, IL. It employs 13,067 people. In Q2 FY2026 it reported revenue of $2.13B and net income of $53M. The market values it at $1.91B.
What do the latest results show for Israel Corporation (IRLCF)?
Short answer · as of
The most recent reported quarter, Q2 FY2026, carried revenue of $2.13B.
Where is operating spending going?
Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.
- Latest quarter · revenue
- $2.13B Jun 30, 2026
- Latest quarter · R&D
- $14.00M Jun 30, 2026
- Latest quarter · SG&A
- $386.00M Jun 30, 2026
- Latest quarter · FMP standardized operating result
- $264.00M Jun 30, 2026
| Period end | Revenue | R&D | SG&A | FMP standardized operating result |
|---|---|---|---|---|
| Jun 30, 2026 | $2.13B | $14.00M | $386.00M | $264.00M |
| Mar 31, 2026 | $2.01B | $14.87M | $380.00M | $227.97M |
| Dec 31, 2025 | $1.74B | $17.35M | $369.46M | $89.81M |
| Sep 30, 2025 | $1.88B | $16.23M | $366.00M | $224.22M |
How to read these figures
Amounts are in US dollars. The operating result is Financial Modeling Prep’s standardized figure, so it can differ from the operating line in the company’s filing. It is not net income or cash flow.
Did results meet expectations?
Reported earnings and revenue alongside the estimates recorded by the provider.
- Latest report · revenue
- $2.01B May 20, 2026
| Report date | Revenue · reported | Revenue · estimate | EPS · reported | EPS · estimate |
|---|---|---|---|---|
| May 20, 2026 | $2.01B | Not available | $0.8300 | Not available |
| Feb 24, 2026 | $1.74B | Not available | −$0.5030 | Not available |
| Nov 19, 2025 | $1.88B | $1.88B | $0.6220 | Not available |
| Aug 12, 2025 | $1.83B | $1.83B | $0.5730 | Not available |
How to read these figures
Dates are when results were reported, not quarter ends. Amounts are in US dollars; EPS is per share. The source does not say whether EPS is basic, diluted or adjusted, so it can differ from the EPS in the income statement.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 FY2026 | $2.13B | $53M | $0.71 (diluted) |
| Q1 FY2026 | $2.01B | $62M | $0.83 (diluted) |
| Q4 FY2025 | $1.74B | -$38M | -$0.50 (diluted) |
| Q3 FY2025 | $1.88B | $47M | $0.62 (diluted) |
What are the financial strengths and risks for Israel Corporation (IRLCF)?
Short answer · as of
Cash and short-term investments were $1.37B at the Jun 30, 2026 balance-sheet date. Operating cash flow was $230.00M for the quarter ended Jun 30, 2026, meaning operations generated cash. These figures do not establish a cash runway. The distress and quality screens read Altman Z 1.32 · Piotroski F 7. Trailing ratios: ROE 4.0% · ROA 0.9% · current ratio 1.70 · earnings yield 6.9% · free-cash-flow yield 4.7%.
How much cash does the business generate or use?
Quarterly operating cash flow shows cash generated or used by operations.
- Latest quarter · operating cash flow
- $230.00M Jun 30, 2026
- Previous quarter · operating cash flow
- $174.45M Mar 31, 2026
| Period end | Operating cash flow | Capital expenditure (reported) |
|---|---|---|
| Jun 30, 2026 | $230.00M | −$197.00M |
| Mar 31, 2026 | $174.45M | −$133.81M |
| Dec 31, 2025 | $238.34M | −$260.87M |
| Sep 30, 2025 | $251.95M | −$181.52M |
How to read these figures
Amounts are in US dollars. Negative operating cash flow means the business used cash. Capital spending is shown as reported; we do not combine it into a free-cash-flow or runway estimate. The bars share one scale.
The records behind this page
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held IRLCF in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported IRLCF in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
Common Questions About IRLCF (Basic Materials)
These answers are editorial: 1 of these 8 answers is drawn from the IRLCF research dossier (written Mar 16, 2026 by gemini-2.0-flash); the other 7 are question templates that restate figures shown above. Figures in this section are not part of the source register.
Is IRLCF a good stock to buy?
Stock Expert AI does not rate IRLCF buy, sell or hold. Israel Corporation Ltd has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the IRLCF stock price today?
The last price recorded for Israel Corporation Ltd (IRLCF), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What do analysts say about IRLCF stock?
Due to the limited coverage of Israel Corporation Ltd as an OTC-listed company, comprehensive analyst reports and ratings may not be readily available. Key valuation metrics to consider include the P/E ratio, profit margin, and dividend yield.
What are the key factors to evaluate for IRLCF?
Evaluate IRLCF on fundamentals, analyst consensus, and risk factors. To weigh it, start with the trailing P/E under Price & valuation on this page. Geographic Expansion in Emerging Markets: Emerging markets in Asia and South America offer significant growth opportunities for Israel Corporation Ltd. These regions are experiencing rapid industrialization and urbanization, driving demand for specialty chemicals and refined products. Not financial advice.
How frequently does IRLCF data refresh on this page?
IRLCF's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven IRLCF's recent stock price performance?
Israel Corporation Ltd (IRLCF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Integrated business model spanning the entire value chain. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider IRLCF overvalued or undervalued right now?
The trailing P/E of Israel Corporation Ltd (IRLCF) is listed under Price & valuation on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research IRLCF before investing?
Before investing in Israel Corporation Ltd (IRLCF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 62 figures on this page — 56 from Financial Modeling Prep (FMP), 3 with no recorded source and 3 computed by us, formula shown in the register. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com